Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Post Marketing Surveillance Study of Actimmune in Patients With Severe, Malignant Osteopetrosis

This study has been completed.
Information provided by:
InterMune Identifier:
First received: August 7, 2002
Last updated: October 30, 2007
Last verified: October 2007
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: September 2005
  Estimated Primary Completion Date: No date given